Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | JSKN033 |
Synonyms | |
Therapy Description |
JSKN033 is a combination of JSKN003, an antibody-drug conjugate (ADC) targeting ERBB2 (HER2), and KN035, a CD274 (PD-L1) inhibitor, which potentially induces antitumor activity (Journal for ImmunoTherapy of Cancer 2024;12). |